All
Patients With Moderate to Severe Alopecia Areata Exhibit Higher Risk of Developing Atopic Dermatitis
July 31st 2024Data from a retrospective analysis demonstrated that patients with moderate to severe alopecia areata are at a higher risk of developing atopic dermatitis compared to those with mild alopecia areata.
The Weekly Roundup: July 22-26
July 26th 2024In case you missed it, this week we had news about the FDA approval of deuruxolitinib for severe alopecia in adults, new nonmelanoma guidelines from the Dermatology Association of Radiation Therapy, Arcutis' submitted sNDA for roflumilast foam for scalp and body psoriasis, and more.